SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-09-023341
Filing Date
2009-04-30
Accepted
2009-04-30 17:11:42
Documents
5
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 v147592_10ka.htm 10-K/A 1159772
2 ex10-3.htm EX-10.3 157581
3 ex10-32.htm EX-10.32 146792
4 v147592_ex31-3.htm EX-31.3 6781
5 v147592_ex31-4.htm EX-31.4 6801
  Complete submission text file 0001144204-09-023341.txt   1479304
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-51531 | Film No.: 09784913
SIC: 2834 Pharmaceutical Preparations